stage I squamous cell carcinoma of the lip and oral cavity
Showing 1 - 25 of >10,000
Oral Cavity Squamous Cell Carcinoma, Stage I Lip and Oral Cavity Cancer AJCC v8, Stage II Lip and Oral Cavity Cancer AJCC v8
Not yet recruiting
- Oral Cavity Squamous Cell Carcinoma
- +4 more
- Near Infrared Imaging
- +2 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Dec 5, 2022
Caregiver, Malignant Head and Neck Tumor, Paranasal Sinus Squamous Cell Carcinoma Trial in Winston-Salem (Communication
Completed
- Caregiver
- +37 more
- Communication Intervention
- +5 more
-
Winston-Salem, North CarolinaComprehensive Cancer Center of Wake Forest University
Dec 14, 2022
Recurrent Adenoid Cystic Carcinoma of the Oral Cavity, Recurrent Mucoepidermoid Carcinoma of the Oral Cavity, Recurrent Squamous
Recruiting
- Recurrent Adenoid Cystic Carcinoma of the Oral Cavity
- +50 more
- transoral robotic surgery
- quality of life assessment
-
Columbus, OhioOhio State University Medical Center
Oct 28, 2022
Head and Neck Carcinoma of Unknown Primary, Locally Advanced Head and Neck Squamous Cell Carcinoma, Locally Advanced
Recruiting
- Head and Neck Carcinoma of Unknown Primary
- +24 more
- Cisplatin
- +2 more
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Aug 6, 2022
Advanced Head and Neck Squamous Cell Carcinoma, Advanced Hypopharyngeal Squamous Cell Carcinoma, Advanced Laryngeal Squamous
Suspended
- Advanced Head and Neck Squamous Cell Carcinoma
- +17 more
- Intensity-Modulated Radiation Therapy
- Peposertib
-
Gilbert, Arizona
- +19 more
Dec 31, 2022
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With
Completed
- Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
- +35 more
- PI3K inhibitor BKM120
- cetuximab
-
Chicago, IllinoisUniversity of Chicago Comprehensive Cancer Center
Sep 14, 2021
Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage III Verrucous Carcinoma of the Oral Cavity, Stage IVA
Withdrawn
- Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity
- +6 more
- hypofractionated radiation therapy
- +3 more
-
New Brunswick, New Jersey
- +1 more
Sep 27, 2022
Buccal Mucosa Squamous Cell Carcinoma, Floor of Mouth Squamous Cell Carcinoma, Gingival Squamous Cell Carcinoma Trial in Canada,
Recruiting
- Buccal Mucosa Squamous Cell Carcinoma
- +11 more
- Computed Tomography (CT)
- +5 more
-
Tucson, Arizona
- +71 more
Jan 11, 2023
Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Metastatic Head and Neck Squamous Cell Carcinoma,
Recruiting
- Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
- +24 more
- Carboplatin
- +2 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
May 18, 2022
Clinical Stage III Human Papillomavirus (HPV)-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage IV
Recruiting
- Clinical Stage III Human Papillomavirus (HPV)-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
- +28 more
- Cisplatin
- +3 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Dec 16, 2022
Oral Cavity Squamous Cell Carcinoma Trial in San Francisco (NisinZ® P, Surgery (non-interventional, standard of care))
Not yet recruiting
- Oral Cavity Squamous Cell Carcinoma
- NisinZ® P
- Surgery (non-interventional, standard of care)
-
San Francisco, CaliforniaUniversity of California, San Francisco
Oct 18, 2023
Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma, Laryngeal Squamous Cell Carcinoma Trial
Not yet recruiting
- Head and Neck Squamous Cell Carcinoma
- +14 more
- Biospecimen Collection
- +9 more
- (no location specified)
Oct 10, 2023
Oral Cavity Squamous Cell Carcinoma Trial in Yichang (Sintilimab, Radiotherapy)
Recruiting
- Oral Cavity Squamous Cell Carcinoma
- Sintilimab
- Radiotherapy
-
Yichang, Hubei, ChinaDepartment of Medical Oncology, Central Hospital of Yichang City
Feb 18, 2023
WORST PATTERN OF INVASION IN ORAL SQUAMOUS CELL CARCINOMA
Recruiting
- Oral Cancer
- +2 more
- Biopsy Specimens Histopathology
-
Rawalpindi, Punjab, PakistanArmed Forces Institute of Pathology
Jun 22, 2023
Squamous Cell Carcinoma of Oral Cavity, Pharynx Carcinoma, Larynx Carcinoma Trial in Gliwice (Chemotherapy
Recruiting
- Squamous Cell Carcinoma of Oral Cavity
- +3 more
- Chemotherapy (carboplatin+paclitaxel) with concomitant low dose ionizing radiotherapy
-
Gliwice, Silesia, PolandThe Maria Sklodowska-Curie National Research Institute of Oncolo
Aug 7, 2023
Squamous Cell Carcinoma, Oral Cavity Squamous Cell Carcinoma Trial in Houston (drug, behavioral, radiation)
Not yet recruiting
- Squamous Cell Carcinoma
- Oral Cavity Squamous Cell Carcinoma
- Tiragolumab
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Jan 27, 2023
Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Metastatic Head and Neck Squamous Cell Carcinoma,
Not yet recruiting
- Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
- +10 more
- Carboplatin
- +9 more
- (no location specified)
Jan 31, 2023
Oral Squamous Cell Carcinoma, Maxillo-facial Surgery, Biomarkers Trial in Amiens (saliva tube)
Recruiting
- Oral Squamous Cell Carcinoma
- +5 more
- saliva tube
-
Amiens, Picardie, FranceAmiens University Hospital
Mar 17, 2023
Squamous Cell Carcinoma of the Oral Cavity Trial in Rouen (Circulating tumor DNA detection)
Not yet recruiting
- Squamous Cell Carcinoma of the Oral Cavity
- Circulating tumor DNA detection
-
Rouen, France
- +1 more
Jun 29, 2023
Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,
Recruiting
- Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
- +26 more
- Biopsy
- +5 more
-
Newark, Delaware
- +52 more
Feb 2, 2023
Oral Squamous Cell Carcinoma Trial in Beijing (Toripalimab)
Not yet recruiting
- Oral Squamous Cell Carcinoma
-
Beijing, ChinaPeking Union Medical College Hospital, Chinese Academy of Medica
Apr 5, 2023
Neoadjuvant Pembrolizumab in III-IVA Resectable Oral Squamous
Recruiting
- Oral Cavity Squamous Cell Carcinoma
-
Guangzhou, Guangdong, ChinaLiuxiqiang
Feb 1, 2023
Squamous Cell Carcinoma of Head and Neck Trial in Hangzhou (Toripalimab)
Recruiting
- Squamous Cell Carcinoma of Head and Neck
-
Hangzhou, Zhejiang, ChinaDepartment of Medical Onocology, First Affiliated Hospital of Zh
Oct 7, 2023
Squamous Cell Carcinoma of the Oral Cavity or Oropharynx Trial (Black Raspberry)
Not yet recruiting
- Squamous Cell Carcinoma of the Oral Cavity or Oropharynx
- Black Raspberry
- (no location specified)
Oct 16, 2023
Oral Cavity Squamous Cell Carcinoma Trial in Leuven (Durvalumab, Durvalumab + Tremelimumab)
Active, not recruiting
- Oral Cavity Squamous Cell Carcinoma
- Durvalumab
- Durvalumab + Tremelimumab
-
Leuven, BelgiumUZ Leuven
May 30, 2022